Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

PF-3644022 (CAS 1276121-88-0)

0.0(0)
Write a reviewAsk a question

Alternate Names:
(10R)-9,10,11,12-Tetrahydro-10-methyl-3-(6-methyl-3-pyridinyl)-8H-[1,4]diazepino[5′,6′:4,5]thieno[3,2-f]quinolin-8-one
CAS Number:
1276121-88-0
Molecular Weight:
374.46
Molecular Formula:
C21H18N4OS
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

PF-3644022 is an exceedingly powerful inhibitor that effectively competes with ATP to target mitogen-activated protein kinase (MAPK)-activated protein kinase-2 (MK2) with remarkable potency (IC50 = 5.2 nM Ki = 3 nM). This compound demonstrates the ability to inhibit the production of tumor necrosis factor α (TNFα) in both U937 monocytic cells and peripheral blood mononuclear cells (PBMCs) with a notable efficacy (IC50 = 160 nM).


PF-3644022 (CAS 1276121-88-0) References

  1. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.  |  Mourey, RJ., et al. 2010. J Pharmacol Exp Ther. 333: 797-807. PMID: 20237073
  2. MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin.  |  Ronkina, N., et al. 2010. Biochem Pharmacol. 80: 1915-20. PMID: 20599781
  3. Microwave-assisted synthesis of 3-aminobenzo[b]thiophene scaffolds for the preparation of kinase inhibitors.  |  Bagley, MC., et al. 2015. Org Biomol Chem. 13: 6814-24. PMID: 26013834
  4. Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2.  |  Alimbetov, D., et al. 2016. Biogerontology. 17: 305-15. PMID: 26400758
  5. Role of MK2 signaling pathway in the chronic compression of cervical spinal cord.  |  Song, H., et al. 2015. Am J Transl Res. 7: 2355-63. PMID: 26807183
  6. Deciphering the true antiproliferative target of an MK2 activation inhibitor in glioblastoma.  |  Brennan, PE. 2016. Cell Death Dis. 7: e2069. PMID: 26821065
  7. Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-Mimetics.  |  Lalaoui, N., et al. 2016. Cancer Cell. 29: 145-58. PMID: 26859455
  8. Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer.  |  Reynoird, N., et al. 2016. Genes Dev. 30: 772-85. PMID: 26988419
  9. Mesenchymal MAPKAPK2/HSP27 drives intestinal carcinogenesis.  |  Henriques, A., et al. 2018. Proc Natl Acad Sci U S A. 115: E5546-E5555. PMID: 29844172
  10. MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma.  |  Berggren, KL., et al. 2019. Oncogene. 38: 7329-7341. PMID: 31417185
  11. Phosphorylated Hsp27 prevents LPS-induced excessive inflammation in THP-1 cells via suppressing ROS-mediated upregulation of CBP.  |  Bi, X., et al. 2020. Cell Biol Int. 44: 253-267. PMID: 31483551
  12. Resveratrol inhibits IL-33-mediated mast cell activation by targeting the MK2/3-PI3K/Akt axis.  |  Nakajima, S., et al. 2019. Sci Rep. 9: 18423. PMID: 31804564
  13. A tumor-specific modulation of heterogeneous ribonucleoprotein A0 promotes excessive mitosis and growth in colorectal cancer cells.  |  Konishi, H., et al. 2020. Cell Death Dis. 11: 245. PMID: 32303675
  14. Role of MK2 signaling pathway mediating microglia/macrophages polarization in chronic compression injury of cervical spinal cord.  |  Yu, L., et al. 2021. Ann Palliat Med. 10: 1304-1312. PMID: 33040559
  15. MKL1 fuels ROS-induced proliferation of vascular smooth muscle cells by modulating FOXM1 transcription.  |  Wu, T., et al. 2023. Redox Biol. 59: 102586. PMID: 36587486

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

PF-3644022, 5 mg

sc-478487
5 mg
$367.00

PF-3644022, 25 mg

sc-478487A
25 mg
$2856.00